The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer

Mazzeschi, M.; Sgarzi, M.*; Romaniello, D.; Gelfo, V.; Cavallo, C.; Ambrosi, F.; Morselli, A.; Miano, C.; Laprovitera, N.; Girone, C.; Ferracin, M.; Santi, S.; Rihawi, K.; Ardizzoni, A.; Fiorentino, M.; D’Uva, G.; Győrffy, B. [Győrffy, Balázs (Onkológia), author] Institute of Enzymology (RCNS); II. Department of Pediatrics (SU / FM / C); Enzim_417 (IMLS); Bioinformatika Tanszék (SU / FM / I); Palmer, R.; Lauriola, M. ✉

English Article (Journal Article) Scientific
Published: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH 0392-9078 1756-9966 41 (1) Paper: 113 , 18 p. 2022
  • SJR Scopus - Cancer Research: Q1
Identifiers
Subjects:
  • Oncology
In the last years, several efforts have been made to classify colorectal cancer (CRC) into well-defined molecular subgroups, representing the intrinsic inter-patient heterogeneity, known as Consensus Molecular Subtypes (CMSs).
Cited in (8)
Citing (2)
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-26 03:50